Literature DB >> 3102715

Total intestinal aganglionosis: a new technique for prolonged survival.

M M Ziegler, A J Ross, H C Bishop.   

Abstract

Total small bowel aganglionosis is uniformly fatal; and prolonged nutritional treatment for the resulting severe short bowel syndrome in the absence of a therapy designed to achieve a functional bowel length has not been warranted. We report an operative technique, long segment small bowel myectomymyotomy, which has produced a functioning length of intestine capable of supporting ever increasing amounts of enteral nutrition. A term female was noted to have neonatal intestinal obstruction, and two laparotomies proved total colonic and near-total small bowel aganglionosis. At 2 months of age reoperation was done and the aganglionosis was proved to extend to 7 cm below the ligament of Treitz. From this transition zone to 10 cm distally, a myectomy was done removing a 1 cm wide length of seromuscular tissue to the level of the submucosa. From the distal end of the myectomy, another 40 cm of bowel received an antimesenteric border myotomy cutting to the submucosal level followed by spreading of the cut surface to a width of 1 cm. This left the patient with 55 to 60 cm of small bowel from the ligament of Treitz to the end of the myotomy at which point an end ostomy was created. The remainder of the small bowel was excised and the colon exteriorized as a mucous fistula. The patient was continued on total parenteral nutrition alone for ten days at which time small volume enteral feeds were introduced. By 5 months of age, 25% of calories were enteral; by 6 months, 33% of calories were enteral; and by 8 months, 45% of intake was enteral.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3102715     DOI: 10.1016/s0022-3468(87)80022-2

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

Review 1.  Hirschsprung's disease--a review.

Authors:  C M Doig
Journal:  Int J Colorectal Dis       Date:  1991-02       Impact factor: 2.571

Review 2.  Hirschsprung's disease: clinical and experimental observations.

Authors:  P Puri
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

3.  A meta-analysis of clinical outcome in patients with total intestinal aganglionosis.

Authors:  Elke Ruttenstock; Prem Puri
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

Review 4.  Knockout mouse models of Hirschsprung's disease.

Authors:  J Zimmer; P Puri
Journal:  Pediatr Surg Int       Date:  2015-07-03       Impact factor: 1.827

5.  A meta-analysis of clinical outcome of intestinal transplantation in patients with total intestinal aganglionosis.

Authors:  Hiroki Nakamura; Davina Henderson; Prem Puri
Journal:  Pediatr Surg Int       Date:  2017-06-09       Impact factor: 1.827

6.  Outcomes of surgical management of total colonic aganglionosis.

Authors:  E K Choe; S B Moon; H Y Kim; S C Lee; K W Park; S E Jung
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

Review 7.  Extended myectomy-myotomy. A therapeutic alternative for total intestinal aganglionosis.

Authors:  M M Ziegler; R E Royal; J Brandt; J Drasnin; L W Martin
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

8.  Long segment Hirschsprung's disease in the Waardenburg-Shah syndrome.

Authors:  E J Gnananayagam; R Solomon; A Chandran; S Anbarasi; S Sen; P D Moses
Journal:  Pediatr Surg Int       Date:  2003-06-14       Impact factor: 1.827

9.  Familial Near-Total Intestinal Aganglionosis.

Authors:  Hidouri Saida; Zitouni Hayet; Chahed Jamila; Mosbahi Sana; Belhassen Samia; Ksiaa Amine; Hmida Badii; Krichene Imed; Sahnoun Lassad; Mekki Mongi; Belguith Mohsen; Nouri Abdellatif
Journal:  J Neonatal Surg       Date:  2017-08-10

10.  Delayed appearance of mature ganglia in an infant with an atypical presentation of total colonic and small bowel aganglionosis: a case report.

Authors:  Fereshteh Salimi Jazi; Julia M Chandler; Chad M Thorson; Tiffany J Sinclair; Florette K Hazard; John A Kerner; Sanjeev Dutta; James C Y Dunn; Stephanie D Chao
Journal:  BMC Pediatr       Date:  2019-04-05       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.